Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 829 results for "gilead sciences"

Daily Dividend Report: CMCSA, MMM, GM, SU, GLW, IR, SEP, GILD, MA

Gilead Sciences to Participate in Two Upcoming Investor Confer...

- 18th Annual BIO CEO & Investor Conference - - Leerink Partners 5th Annual Global Healthcare Conference - - Webcasts Available Through Gilead Corporate Website - Company Website: FOSTER CITY, Calif. -- (Business Wire) ... Stockwatch, 1 hour ago
Gilead: Competition Worries Are Overblown Seeking Alpha, 3 days ago

129 images for gilead sciences

American Banking News - Earnings, 5 hours ago, 3 days ago
The World, 19 hours ago
Octafinance, 5 days ago, 8 hours ago
Octafinance, 5 days ago
Octafinance, 5 days ago
Octafinance, 5 days ago
Octafinance, 5 days ago
Octafinance, 5 days ago
Bidness Etc

Accident Compensation Corp Invests $2,415,000 in Gilead Sciences, Inc. (GILD)

Accident Compensation Corp acquired a new stake in Gilead Sciences, Inc. (NASDAQ:GILD) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 23,861 ...
 SleekMoney2 hours ago Gilead Sciences (GILD) Buy Rating Reiterated at RBC Capital  Mideast Time3 hours ago BB&T Corp Sells 12,639 Shares of Gilead Sciences, Inc. (GILD)  SleekMoney6 hours ago Celgene, Gilead Sciences shares could rise 30 percent: Barron's  4 Traders20 hours ago

Will Gilead Sciences, Inc. Continue to Dominate HIV Treatment?

After apparently losing market share within the multibillion dollar market for medicineused to treat HIV, is Gilead Sciences ' ( NASDAQ:GILD ) reign as the top drugmaker coming to a close? In thisclip of Industry Focus: Healthcare , Motley Fool ...
 Motley Fool4 hours ago

The Pipeline: An Unappreciated Part Of Gilead's Value Story

Last week, I did part one of a three-part overview on Gilead Sciences (NASDAQ: GILD ) after the company once again posted blow out quarterly results. That article looked at some of those earnings highlights and the guidance for the year ahead. More ...
 Seeking Alpha10 hours ago

Capital Management Owns $9.982 Mln Worth Stake In Gilead Sciences

According to its most recent Form 13F filing with the Securities and Exchange Commission, the institutional investor's holdings in Gilead Sciences were worth $9.982 million. Capital Management bought an additional 13,389 shares during the fourth ...
 Nasdaq15 hours ago
Motley Fool

Is Gilead Sciences Finally Nearing a Bottom?

To be perfectly clear, this is not a get-rich action that my Foolish colleagues and I came up with. But we wouldn't argue with the approach. A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich" rated The ...
 Motley Fool1 day ago

Gilead Sciences (GILD) Stock Gets Outperform Rating at Leerink

NEW YORK (TheStreet) -- Leerink reassumed coverage of Gilead Sciences (GILD - Get Report) stock with an "outperform" rating and $125 price target on Thursday night. The Foster City, CA-based biopharmaceutical company discovers, develops and ...
 TheStreet.com3 days ago Why Gilead Sciences (GILD) Stock May Advance Today  TheStreet.com8 hours ago Gilead Sciences Rallies Off Q4 Report  Benzinga.com5 days ago Gilead (GILD) Stock Gains as Analysts Discuss Earnings Results  TheStreet.com5 days ago
Bidness Etc

Here is Why Gilead Sciences, Inc May Fall Despite Earnings Beat

Gilead Sciences, Inc. ( NASDAQ:GILD ) announced its fourth quarter earnings yesterday, after the markets closed. The biotech giant topped analysts estimates for both earnings and revenue. The company reported a profit of $4.68 billion, or $3.18 ...
 Bidness Etc4 days ago Gilead Sciences, Inc. Gains After Earnings (GILD)  InvestorPlace.com3 days ago Gilead Faces Its Great Hep C Threat: Will It Change Earnings?  Benzinga.com6 days ago Why Gilead Sciences, Inc Stock Can Fall on Q4 Earnings  Bidness Etc6 days ago

Grading Gilead Sciences' Performance in 2015

Gilead Sciences ( NASDAQ:GILD ) had a lot of exciting news to report to shareholders in their earnings call this week. In this week's HealthcareIndustry Focus , Kristine Harjes, Todd Campbell, and Michael Douglass go over the numbers, and how ...
 Motley Fool2 days ago
Motley Fool

1 Company Gilead Sciences Should Consider Buying Right Now

Image source: Centers for Disease Control and Prevention. In case you missed it, biotech blue-chip Gilead Sciences ( NASDAQ:GILD ) reported its fourth-quarter and full-year financial results on Tuesday. Growth concerns weigh on Gilead The ...
 Motley Fool2 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - gilead sciences
Get updated on latest news & your favorite topics right in your inbox!
More     Less